microdosing glp 1 for menopause THE PCCA BLOG Menopause Weight Challenges: GLP-1 ID

For individuals managing weight or metabolic health while breastfeeding, this decision requires balancing treatment goals with infant safety

On time

& Foster-Schubert, K

Fadini GP, Longato E, Morieri ML, Del Prato S, Avogaro A, Solini A (2024) Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

Crucially, the absence of a randomized control group limits the ability to establish causality definitively

Earlier readout in non-diabetics showed ~12.4% , at the lower end of expectationsstill clinically meaningful but shy of leading injectables